|
72 |
Genematrix expands multiplex diagnosis product line-up applying real-time PCR
|
2017.09.27 |
|
71 |
Genematrix acquired product license for sexual transmitted infection diagnostic kit
|
2017.07.19 |
|
70 |
Genematrix signed a contract for development of multi-molecular diagnostic kits including Zika virus detection
|
2017.07.03 |
|
69 |
HBI, 'AIDS/syphilis test' listed as a recommended test in the Philippines
|
2017.05.25 |
|
68 |
Genematrix acquired a patent on genetic analysis method
|
2017.05.17 |
|
67 |
Genematrix successfully developed a new product that simultaneously diagnoses 7 sexually transmitted diseases
|
2017.03.08 |
|
66 |
HBI acquired approval for manufacturing cervical cancer diagnosis product from the Ministry of Food and Drug Safety
|
2017.02.16 |
|
65 |
Genematrix signed an agreement with Luminex for commercialization of molecular diagnostic products
|
2016.11.01 |
|
64 |
Genematrix received project for Zika virus vaccine development with disease management headquarters service
|
2016.09.29 |
|
63 |
Agreement on the development of new/variant respiratory pathogen diagnosis system
|
2016.09.05 |
|
62 |
Genematrix acquired European patent for gene amplification method
|
2016.07.11 |
|
61 |
Genematrix commercializes early diagnosis products for myocardial infarction
|
2016.05.11 |
|
60 |
Genematrix secured proprietary technology for next-generation molecular diagnostics
|
2016.04.25 |
|
59 |
Genematrix secured advanced prediction technology for response of liver cancer treatment
|
2016.03.23 |
|
58 |
Reimbursement : Hepatitis B drug resistance diagnosis product
|
2015.04.20 |
ENG